Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
new york
10
×
life sciences
national blog main
new york blog main
new york top stories
boston blog main
clinical trials
national top stories
boston top stories
amgen
inclisiran
regeneron pharmaceuticals
san francisco blog main
alnylam pharmaceuticals
biotech
pcsk9 inhibitors
san francisco top stories
sanofi
alirocumab
cholesterol
drugs
evolocumab
fda
pcsk9
praluent
repatha
rna interference
san diego blog main
san diego top stories
the medicines co.
abbvie
acorda therapeutics
acute migrane
akcea therapeutics
akili interactive labs
allergan
alzheimer's
ampyra
anylam pharmaceuticals
apokyn
What
drug
10
×
medicines
approved
cholesterol
fda
medco
new
disease
lowering
medicine
patients
alnylam
announced
company
data
looms
meant
pfizer
twice
year
aces
acorda
acquire
activity
admi
ago
agreed
akcea
altoida
amyloidosis
attr
augmented
available
backs
based
battle
bets
big
billion
biotech
Language
unset
Current search:
drug
×
" new york "
×
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B
@xconomy.com
4 years ago
MedCo Preps for FDA Filing as Cholesterol Drug Clears Last Two Tests
@xconomy.com
4 years ago
As Cholesterol Drug Aces Big Test, MedCo CEO Open to Flexible Pricing
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs
@techcrunch.com
4 years ago
Using augmented reality, Altoida is identifying the likely onset of neurodegenerative diseases
@xconomy.com
4 years ago
MedCo Touts New Data for Long-Lasting Heart Drug as Reckoning Looms
@xconomy.com
5 years ago
FDA OKs Pfizer Rare Disease Drug, Sets Up Battle With Alnylam, Akcea
@xconomy.com
5 years ago
With New Data, Intercept On Track for First-Ever Approved NASH Drug
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Sanofi Backs Click Therapeutics as Digital Medicines Gain Momentum